Under ASX listing rules the company MUST report significant events as these occur. Whether it reports these openly and honestly (i.e. receipt of a CRL from the FDA) or deceptively, as it did is a matter for the ASX and ASIC to police (which they do not do well).
Expectations for November, page-3
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.010(9.09%) |
Mkt cap ! $49.44M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 12.0¢ | 11.0¢ | $24.28K | 213.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 327940 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 223928 | 12 |
View Market Depth
| Last trade - 16.10pm 22/05/2024 (20 minute delay) ? |
|
|||||
|
Last
11.3¢ |
Change
0.010 ( 2.27 %) |
||||
| Open | High | Low | Volume | ||
| 11.5¢ | 12.0¢ | 11.0¢ | 98462 | ||
| Last updated 15.59pm 22/05/2024 ? | |||||
| SPL (ASX) Chart |